{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:01:06Z","timestamp":1790780466562,"version":"4.1.0"},"reference-count":225,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused the Coronavirus disease 2019 (COVID-19) pandemic, has posed significant healthcare challenges. In addition to respiratory complications, it has led to severe damage in other organs, particularly the cardiovascular system. Of which, myocardial injury is increasingly recognized as a most significant complication, contributing to the high mortality. Recent research indicates the pivotal role of immune dysregulation in mediating myocardial injury in patients infected with SARS-CoV-2. In this review, we provide a comprehensive analysis of the immune mechanisms involved in SARS-CoV-2-induced myocardial damage, focusing on the roles of key immune cells and molecules that contribute to this pathological process. Aiming at mitigating the myocardial injury of COVID-19, we review immune-based treatments under evaluation in preclinical and clinical trials. Along with talking about the similarities and differences in myocardial injury resulting from SARS-CoV-2, the Middle East respiratory syndrome coronavirus (MERS-CoV) and the severe acute respiratory syndrome coronavirus (SARS-CoV). This article provides a unique perspective on using past experiences to prevent myocardial injury in the face of ongoing virus mutations.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1561946","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:11:25Z","timestamp":1747195885000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhaoqing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luning","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Ming","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_839_21","article-title":"Sars, Mers and Covid-19: an overview and comparison of clinical, laboratory and radiological features","volume":"11","author":"Pustake","year":"2022","journal-title":"J Family Med Prim Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijsu.2020.07.032","article-title":"A comparative overview of Covid-19, Mers and Sars: review article","volume":"81","author":"Liu","year":"2020","journal-title":"Int J Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and renal tropism of Sars-Cov-2","volume":"383","author":"Puelles","year":"2020","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157053","article-title":"Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after Sars-Cov-2 infection","volume":"7","author":"Durstenfeld","year":"2022","journal-title":"JCI Insight"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2024.06.008","article-title":"Clinical significance of myocardial injury in patients hospitalized for Covid-19: A prospective, multicenter, cohort study","volume":"17","author":"Shiwani","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047349","article-title":"Description and proposed management of the acute Covid-19 cardiovascular syndrome","volume":"141","author":"Hendren","year":"2020","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.11.013","article-title":"Cardiovascular complications are the primary drivers of mortality in hospitalized patients with Sars-Cov-2 community-acquired pneumonia","volume":"163","author":"Ali","year":"2023","journal-title":"Chest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.tem.2020.10.001","article-title":"Cardiovascular manifestations and mechanisms in patients with Covid-19","volume":"31","author":"Dou","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/cvr\/cvae159","article-title":"Covid-19 related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac mri abnormalities","volume":"120","author":"Corovic","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01179-24","article-title":"Infiltrating monocytes drive cardiac dysfunction in a cardiomyocyte-restricted mouse model of Sars-Cov-2 infection","volume":"98","author":"Dmytrenko","year":"2024","journal-title":"J Virol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of Covid-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s41232-023-00259-5","article-title":"Innate immune recognition against Sars-Cov-2","volume":"43","author":"Yamada","year":"2023","journal-title":"Inflammation Regener"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104960","article-title":"Interferon at the crossroads of Sars-Cov-2 infection and Covid-19 disease","volume":"299","author":"Samuel","year":"2023","journal-title":"J Biol Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to Sars-Cov-2 and Covid-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nri3818","article-title":"The ins and outs of mhc class ii-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.915604","article-title":"Editorial: novel platform for antigen delivery to dendritic cells for immunotherapy","volume":"13","author":"Plantinga","year":"2022","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25866","article-title":"Mathematical modeling of interaction between innate and adaptive immune responses in Covid-19 and implications for viral pathogenesis","volume":"92","author":"Du","year":"2020","journal-title":"J Med Virol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to Sars-Cov-2 drives development of Covid-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate immunity: the first line of defense against Sars-Cov-2","volume":"23","author":"Diamond","year":"2022","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41467-021-27716-4","article-title":"Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive Covid-19","volume":"13","author":"Unterman","year":"2022","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab201","article-title":"Covid-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the esc working group on cellular biology of the heart","volume":"117","author":"Pesce","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1038\/s41598-021-83822-9","article-title":"Association of coagulation dysfunction with cardiac injury among hospitalized patients with Covid-19","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.3390\/v14102149","article-title":"Evaluation of cardiac biomarkers and expression analysis of il-1, il-6, il-10, il-17, and il-25 among Covid-19 patients from Pakistan","volume":"14","author":"Ullah","year":"2022","journal-title":"Viruses"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01063-21","article-title":"Functional effects of cardiomyocyte injury in Covid-19","volume":"96","author":"Siddiq","year":"2022","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2020.05.013","article-title":"Special article - acute myocardial injury in patients hospitalized with Covid-19 infection: A review","volume":"63","author":"Bavishi","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.69677","article-title":"Manifestations and mechanism of Sars-Cov2 mediated cardiac injury","volume":"18","author":"Xu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.05.001","article-title":"Recognizing Covid-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management","volume":"17","author":"Siripanthong","year":"2020","journal-title":"Heart Rhythm"},{"key":"B31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/cells11040611","article-title":"Activation of immune system may cause pathophysiological changes in the myocardium of Sars-Cov-2 infected monkey model","volume":"11","author":"Rabbani","year":"2022","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042921-112837","article-title":"Cytokine storm syndrome","volume":"74","author":"Cron","year":"2023","journal-title":"Annu Rev Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad174","article-title":"Proinflammatory cytokines driving cardiotoxicity in Covid-19","volume":"120","author":"Colzani","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2021.02.007","article-title":"Hyper-inflammatory response involves in cardiac injury among patients with Coronavirus disease 2019","volume":"361","author":"Xia","year":"2021","journal-title":"Am J Med Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with Coronavirus disease 2019 (Covid-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.3390\/ijms252111411","article-title":"Cytokine storm in Covid-19: exploring il-6 signaling and cytokine-microbiome interactions as emerging therapeutic approaches","volume":"25","author":"Paranga","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.chom.2022.12.005","article-title":"An epithelial-immune circuit amplifies inflammasome and il-6 responses to Sars-Cov-2","volume":"31","author":"Barnett","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1033674","article-title":"The role of il-6 in coronavirus, especially in Covid-19","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-023-1044-4","article-title":"Cytokine storm and translating il-6 biology into effective treatments for Covid-19","volume":"17","author":"Li","year":"2023","journal-title":"Front Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00724-14","article-title":"Interleukin-6 (Il-6) and il-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function","volume":"88","author":"Hou","year":"2014","journal-title":"J Virol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.35772\/ghm.2021.01090","article-title":"Interleukin-6 is upregulated and may be associated with myocardial injury in some patients who have recovered from Covid-19","volume":"4","author":"Hayama","year":"2022","journal-title":"Glob Health Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255976","article-title":"Covid19-associated cardiomyocyte dysfunction, arrhythmias and the effect of canakinumab","volume":"16","author":"Dimai","year":"2021","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00714-3","article-title":"Inflammatory cytokines and cardiac arrhythmias: the lesson from Covid-19","volume":"22","author":"Lazzerini","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.893681","article-title":"Interleukin-6 elevation is a key pathogenic factor underlying Covid-19-associated heart rate-corrected qt interval prolongation","volume":"9","author":"Lazzerini","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41598-022-04852-5","article-title":"Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases","volume":"12","author":"Zhu","year":"2022","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-311079","article-title":"Systemic inflammation as a novel qt-prolonging risk factor in patients with torsades de pointes","volume":"103","author":"Lazzerini","year":"2017","journal-title":"Heart"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156514","article-title":"Il-6 is a predictor and potential therapeutic target for Coronavirus disease 2019-related heart failure: A single-center retrospective study","volume":"176","author":"Xi","year":"2024","journal-title":"Cytokine"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3153","article-title":"Il-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat\u00a0Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"9058","DOI":"10.3390\/ijms23169058","article-title":"A comparative study of the plasma chemokine profile in Covid-19 patients infected with different Sars-Cov-2 variants","volume":"23","author":"Korobova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0881","article-title":"Human-induced pluripotent stem cell-derived cardiomyocytes platform to study Sars-Cov-2 related myocardial injury","volume":"84","author":"Wong","year":"2020","journal-title":"Circ J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3390\/vaccines9111224","article-title":"The involvement of cxc motif chemokine ligand 10 (Cxcl10) and its related chemokines in the pathogenesis of coronary artery disease and in the Covid-19 vaccination: A narrative review","volume":"9","author":"Karimabad","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.thromres.2021.06.003","article-title":"C-C motive chemokine ligand 2 and thromboinflammation in Covid-19-associated pneumonia: A\u00a0retrospective study","volume":"204","author":"Nieri","year":"2021","journal-title":"Thromb Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.05.025","article-title":"Chemokine cc-motif ligand 2 participates in platelet function and arterial thrombosis by regulating pkcalpha-P38mapk-hsp27 pathway","volume":"1864","author":"Liu","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.975367","article-title":"Role of the ccl2-ccr2 axis in cardiovascular disease: pathogenesis and clinical implications","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/jcm8050708","article-title":"Systemic inflammation in metabolic syndrome: increased platelet and leukocyte activation, and key role of cx(3)Cl1\/cx(3)Cr1 and ccl2\/ccr2 axes in arterial platelet-proinflammatory monocyte adhesion","volume":"8","author":"Marques","year":"2019","journal-title":"J Clin Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2021.07.012","article-title":"Cardiomyocytes recruit monocytes upon Sars-Cov-2 infection by secreting ccl2","volume":"16","author":"Yang","year":"2021","journal-title":"Stem Cell Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.123.066433","article-title":"Virus-induced acute respiratory distress syndrome causes cardiomyopathy through eliciting inflammatory responses in the heart","volume":"150","author":"Grune","year":"2024","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.02.019","article-title":"Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against Sars-Cov-2","volume":"12","author":"Aliyari","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and type iii interferons - induction, signaling, evasion, and application to combat Covid-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-022-01651-y","article-title":"Innate immune response and inflammasome activation during Sars-Cov-2 infection","volume":"45","author":"Islamuddin","year":"2022","journal-title":"Inflammation"},{"key":"B62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41392-020-00438-7","article-title":"Severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) membrane (M) protein inhibits type I and iii interferon production by targeting rig-I\/mda-5 signaling","volume":"5","author":"Zheng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108234","article-title":"Evasion of type I interferon by Sars-Cov-2","volume":"33","author":"Xia","year":"2020","journal-title":"Cell Rep"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-ii-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00299-20","article-title":"Critical determinants of cytokine storm and type I interferon response in Covid-19 pathogenesis","volume":"34","author":"Ramasamy","year":"2021","journal-title":"Clin Microbiol Rev"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe Covid-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","article-title":"Untuned antiviral immunity in Covid-19 revealed by temporal type I\/iii interferon patterns and flu comparison","volume":"22","author":"Galani","year":"2021","journal-title":"Nat Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in Sars-Cov-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00592-0","article-title":"Type I and iii interferon responses in Sars-Cov-2 infection","volume":"53","author":"Kim","year":"2021","journal-title":"Exp Mol Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00839-1","article-title":"Innate immune evasion strategies of Sars-Cov-2","volume":"21","author":"Minkoff","year":"2023","journal-title":"Nat\u00a0Rev Microbiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2135","article-title":"Innate immune evasion by Sars-Cov-2: comparison with Sars-Cov","volume":"30","author":"Bouayad","year":"2020","journal-title":"Rev Med Virol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2021.03.007","article-title":"Loss of sarcomeric proteins via upregulation of jak\/stat signaling underlies interferon-gamma-induced contractile deficit in engineered human myocardium","volume":"126","author":"Zhan","year":"2021","journal-title":"Acta Biomater"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00862-21","article-title":"Sars-Cov-2 disrupts proximal elements in the jak-stat pathway","volume":"95","author":"Chen","year":"2021","journal-title":"J Virol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by Sars-Cov-2","volume":"11","author":"Lei","year":"2020","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01928-20","article-title":"Antiviral activity of type I, II, and III interferons counterbalances ace2 inducibility and restricts Sars-Cov-2","volume":"11","author":"Busnadiego","year":"2020","journal-title":"mBio"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2022.107447","article-title":"Cardiac macrophage density in Covid-19 infection: relationship to myocyte necrosis and acute lung injury","volume":"60","author":"Jum\u2019ah","year":"2022","journal-title":"Cardiovasc Pathol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102833","article-title":"Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe Covid-19 patients","volume":"57","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"key":"B78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/CIRCRESAHA.121.319060","article-title":"An immuno-cardiac model for macrophage-mediated inflammation in Covid-19 hearts","volume":"129","author":"Yang","year":"2021","journal-title":"Circ Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with Covid-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jneuroim.2018.09.003","article-title":"Therapeutic potentials of ginger for treatment of multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties","volume":"324","author":"Jafarzadeh","year":"2018","journal-title":"J Neuroimmunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab298","article-title":"Cardiovascular disease and Covid-19: A consensus paper from the esc working group on coronary pathophysiology & microcirculation, esc working group on thrombosis and the association for acute cardiovascular care (Acvc), in collaboration with the European heart rhythm association (Ehra)","volume":"117","author":"Cenko","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101311","article-title":"The future landscape of macrophage research in cardiovascular disease: A bibliometric analysis","volume":"47","author":"Xu","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/ijms22020559","article-title":"Neutrophil extracellular traps and their implications in cardiovascular and inflammatory disease","volume":"22","author":"Klopf","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/ijms24021266","article-title":"Platelet-neutrophil crosstalk in thrombosis","volume":"24","author":"Mereweather","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.immuni.2022.10.001","article-title":"Neutrophil \u201cPlucking\u201d on megakaryocytes drives platelet production and boosts cardiovascular disease","volume":"55","author":"Petzold","year":"2022","journal-title":"Immunity"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1692983","article-title":"Platelet-neutrophil crosstalk in atherothrombosis","volume":"119","author":"Pircher","year":"2019","journal-title":"Thromb Haemost"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2021.09.004","article-title":"Coronavirus disease 2019 (Covid-19) coronary vascular thrombosis: correlation with neutrophil but not endothelial activation","volume":"192","author":"Johnson","year":"2022","journal-title":"Am J Pathol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1026866","article-title":"Neutrophil infiltration and myocarditis in patients with severe Covid-19: A post-mortem study","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13223","article-title":"Immunopathological characteristics of Coronavirus disease 2019 cases in Guangzhou, China","volume":"160","author":"Tan","year":"2020","journal-title":"Immunology"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with Coronavirus 2019 (Covid-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.09.022","article-title":"Neutrophil-to-lymphocyte ratio on admission is an independent risk factor for the severity and mortality in patients with Coronavirus disease 2019","volume":"82","author":"Wang","year":"2021","journal-title":"J Infect"},{"key":"B93","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.thromres.2020.05.006","article-title":"The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in Covid-19: A retrospective study in Suzhou China","volume":"192","author":"Fu","year":"2020","journal-title":"Thromb Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106017","article-title":"Neutrophil-to-lymphocyte ratio and clinical outcome in Covid-19: A report from the Italian front line","volume":"56","author":"Ciccullo","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"B95","doi-asserted-by":"publisher","first-page":"100422","DOI":"10.1016\/j.cpcardiol.2019.04.002","article-title":"Reference values for neutrophil to lymphocyte ratio (Nlr), a biomarker of cardiovascular risk, according to age and sex in a Latin American population","volume":"46","author":"Huguet","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.1042","article-title":"Association of neutrophil-to-lymphocyte ratio with mortality and cardiovascular disease in the Jackson heart study and modification by the Duffy antigen variant","volume":"3","author":"Kim","year":"2018","journal-title":"JAMA Cardiol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13006","article-title":"Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: A cohort study","volume":"13","author":"Saliba","year":"2015","journal-title":"J Thromb Haemost"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mrna-based Covid-19 vaccination in the us from December 2020 to August 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004056","article-title":"Postmarketing active surveillance of myocarditis and pericarditis following vaccination with Covid-19 mrna vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study","volume":"19","author":"Massari","year":"2022","journal-title":"PloS Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069445","article-title":"Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following Covid-19 vaccination: living evidence syntheses and review","volume":"378","author":"Pillay","year":"2022","journal-title":"BMJ"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00842-X","article-title":"Covid-19 mrna vaccination and myocarditis or pericarditis","volume":"399","author":"Husby","year":"2022","journal-title":"Lancet"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00791-7","article-title":"Risk of myocarditis and pericarditis after the covid-19 mrna vaccination in the USA: A cohort study in claims databases","volume":"399","author":"Wong","year":"2022","journal-title":"Lancet"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with Covid-19 mrna vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeab230","article-title":"Myocarditis following Covid-19 vaccination: magnetic resonance imaging study","volume":"23","author":"Shiyovich","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-08566-0","article-title":"Cardiac magnetic resonance imaging of myocarditis and pericarditis following Covid-19 vaccination: A multicenter collection of 27 cases","volume":"32","author":"Di Dedda","year":"2022","journal-title":"Eur Radiol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.961031","article-title":"Immunological Response and Temporal Associations in Myocarditis after Covid-19 Vaccination Using Cardiac Magnetic Resonance Imaging: An Amplified T-Cell Response at the Heart of It","volume":"9","author":"Vago","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"6940","DOI":"10.3390\/ijms23136940","article-title":"Intramyocardial inflammation after Covid-19 vaccination: an endomyocardial biopsy-proven case series","volume":"23","author":"Baumeier","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating spike protein detected in post-Covid-19 mrna vaccine myocarditis","volume":"147","author":"Yonker","year":"2023","journal-title":"Circulation"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103807","article-title":"Lack of evidence of significant homology of Sars-Cov-2 spike sequences to myocarditis-associated antigens","volume":"75","author":"Marrama","year":"2022","journal-title":"EBioMedicine"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2021-0435-SA","article-title":"Autopsy histopathologic cardiac findings in 2 adolescents following the second Covid-19 vaccine dose","volume":"146","author":"Gill","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2022.08.026","article-title":"Clinical cardiovascular emergencies and the cellular basis of Covid-19 vaccination: from dream to reality","volume":"124","author":"Li","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102463","article-title":"Assessing ace2 expression patterns in lung tissues in the pathogenesis of Covid-19","volume":"112","author":"Li","year":"2020","journal-title":"J Autoimmun"},{"key":"B113","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12916-020-01673-z","article-title":"New insights into genetic susceptibility of Covid-19: an ace2 and tmprss2 polymorphism analysis","volume":"18","author":"Hou","year":"2020","journal-title":"BMC Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s42003-021-02030-3","article-title":"Human ace2 receptor polymorphisms and altered susceptibility to Sars-Cov-2","volume":"4","author":"Suryamohan","year":"2021","journal-title":"Commun Biol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105781","article-title":"Global distribution of ace1 (Rs4646994) and ace2 (Rs2285666) polymorphisms associated with Covid-19: A systematic review and meta-analysis","volume":"172","author":"Keikha","year":"2022","journal-title":"Microb Pathog"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2239952","article-title":"Host genetic polymorphisms involved in long-term symptoms of Covid-19","volume":"12","author":"Udomsinprasert","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812940","article-title":"Ace and ace2 gene variants are associated with severe outcomes of Covid-19 in men","volume":"13","author":"Martinez-Gomez","year":"2022","journal-title":"Front Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.08.011","article-title":"Hla alleles: important pieces to the Covid-19 puzzle","volume":"44","author":"Castro-Santos","year":"2023","journal-title":"Trends Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06331-x","article-title":"A common allele of hla is associated with asymptomatic Sars-Cov-2 infection","volume":"620","author":"Augusto","year":"2023","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40001-021-00563-1","article-title":"Association between hla genotypes and Covid-19 susceptibility, severity and progression: A comprehensive review of the literature","volume":"26","author":"Migliorini","year":"2021","journal-title":"Eur J Med Res"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01071-x","article-title":"Mhc haplotyping of Sars-Cov-2 patients: hla subtypes are not associated with the presence and severity of Covid-19 in the Israeli population","volume":"41","author":"Ben Shachar","year":"2021","journal-title":"J Clin Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.622176","article-title":"Genetics insight for Covid-19 susceptibility and severity: A review","volume":"12","author":"Fricke-Galindo","year":"2021","journal-title":"Front Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-024-00204-w","article-title":"Impacts of inflammatory cytokines variants on systemic inflammatory profile and Covid-19 severity","volume":"14","author":"Deng","year":"2024","journal-title":"J Epidemiol Glob Health"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad723","article-title":"Long covid and its cardiovascular implications: A call to action","volume":"44","author":"Al-Aly","year":"2023","journal-title":"Eur\u00a0Heart J"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac031","article-title":"Long covid: post-acute sequelae of Covid-19 with a cardiovascular focus","volume":"43","author":"Raman","year":"2022","journal-title":"Eur Heart J"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2022.12.002","article-title":"Objective hemodynamic cardiovascular autonomic abnormalities in post-acute sequelae of Covid-19","volume":"39","author":"Hira","year":"2023","journal-title":"Can J Cardiol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101186","article-title":"Covid-19 cardiovascular connection: A review of cardiac manifestations in Covid-19 infection and treatment modalities","volume":"48","author":"Maitz","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.120.008791","article-title":"Il-6 (Interleukin 6) blockade and heart rate corrected qt interval prolongation in Covid-19","volume":"13","author":"Lazzerini","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/08998280.2021.1961571","article-title":"Relation of interleukin-6 levels in Covid-19 patients with major adverse cardiac events","volume":"35","author":"Nguyen","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"B130","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.2021.11330","article-title":"Association between administration of il-6 antagonists and mortality among patients hospitalized for Covid-19: A meta-analysis","volume":"326","author":"Shankar-Hari","year":"2021","journal-title":"JAMA"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1172\/jci138554","article-title":"Impaired immune cell cytotoxicity in severe Covid-19 is il-6 dependent","volume":"130","author":"Mazzoni","year":"2020","journal-title":"J Clin Invest"},{"key":"B132","doi-asserted-by":"publisher","first-page":"16826","DOI":"10.1038\/s41598-020-74001-3","article-title":"Preemptive interleukin-6 blockade in patients with Covid-19","volume":"10","author":"Guillen","year":"2020","journal-title":"Sci Rep"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13163","article-title":"Use of the il-6r antagonist tocilizumab in hospitalized Covid-19 patients","volume":"289","author":"Patel","year":"2021","journal-title":"J Intern Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1136\/annrheumdis-2020-218715","article-title":"Response to: \u2018Correspondence on \u2018Interleukin-6 blockade with subcutaneous tocilizumab in severe Covid-19 pneumonia and hyperinflammation: A case-control study\u2019 by Potere et\u00a0al\u2019 by Buckley","volume":"81","author":"Potere","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668507","article-title":"Interleukin-6, cxcl10 and infiltrating macrophages in Covid-19-related cytokine storm: not one for all but all for one","volume":"12","author":"Coperchini","year":"2021","journal-title":"Front\u00a0Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2021.1919086","article-title":"The role of il-6 and il-6 blockade in Covid-19","volume":"17","author":"Potere","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107825","article-title":"Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor ccr5 in Covid-19 severity","volume":"98","author":"Cuesta-Llavona","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104902","article-title":"The chemokine receptor antagonist cenicriviroc inhibits the replication of Sars-Cov-2 in vitro","volume":"182","author":"Okamoto","year":"2020","journal-title":"Antiviral Res"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6363760","article-title":"Genetic variation at the chemokine receptors ccr5\/ccr2 in myocardial infarction","volume":"2","author":"Gonzalez","year":"2001","journal-title":"Genes Immun"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010547","article-title":"Rationale of using the dual chemokine receptor ccr2\/ccr5 inhibitor cenicriviroc for the treatment of Covid-19","volume":"18","author":"Files","year":"2022","journal-title":"PloS Pathog"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-019-0159-x","article-title":"Exosomes from mesenchymal stem\/stromal cells: A new therapeutic paradigm","volume":"7","author":"Yin","year":"2019","journal-title":"Biomark Res"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.06.024","article-title":"Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for the treatment of respiratory failure from Covid-19: A randomized, placebo-controlled dosing clinical trial","volume":"164","author":"Lightner","year":"2023","journal-title":"Chest"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.05.009","article-title":"Mesenchymal stem cell-based therapy for cardiovascular disease: progress and challenges","volume":"26","author":"Bagno","year":"2018","journal-title":"Mol Ther"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.029","article-title":"Comparing hospitalised, community and staff Covid-19 infection rates during the early phase of the evolving Covid-19 epidemic","volume":"81","author":"Tang","year":"2020","journal-title":"J Infect"},{"key":"B145","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41392-020-00286-5","article-title":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with Covid-19: A phase 1 clinical trial","volume":"5","author":"Meng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ace2(-) mesenchymal stem cells improves the outcome of patients with Covid-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-021-00573-y","article-title":"Mesenchymal stem cell treatment improves outcome of Covid-19 patients via multiple immunomodulatory mechanisms","volume":"31","author":"Zhu","year":"2021","journal-title":"Cell Res"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-021-00161-z","article-title":"Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in Covid-19 patients with ards","volume":"6","author":"Shetty","year":"2021","journal-title":"NPJ Regener Med"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70217-6","article-title":"Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ards and sepsis","volume":"2","author":"Walter","year":"2014","journal-title":"Lancet Respir Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq238","article-title":"C-reactive protein is a mediator of cardiovascular disease","volume":"31","author":"Bisoendial","year":"2010","journal-title":"Eur Heart J"},{"key":"B151","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/cells8080784","article-title":"Mesenchymal stem cell migration and tissue repair","volume":"8","author":"Fu","year":"2019","journal-title":"Cells"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103789","article-title":"Human mesenchymal stem cells treatment for severe Covid-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial","volume":"75","author":"Shi","year":"2022","journal-title":"EBioMedicine"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.020","article-title":"Mesenchymal stem cell therapy in severe Covid-19: A retrospective study of short-term treatment efficacy and side effects","volume":"81","author":"Chen","year":"2020","journal-title":"J\u00a0Infect"},{"key":"B154","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13287-022-02972-3","article-title":"One-year follow-up study after patients with severe Covid-19 received human umbilical cord mesenchymal stem cells treatment","volume":"13","author":"Shi","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104600","article-title":"Human mesenchymal stem cell therapy in severe Covid-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial","volume":"92","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"key":"B156","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13287-021-02165-4","article-title":"Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill Covid-19-induced ards patients: A case series","volume":"12","author":"Hashemian","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03522-1","article-title":"Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-Covid-19 syndrome: an intermediate-size expanded access program","volume":"14","author":"Vij","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"B158","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00395-022-00914-x","article-title":"On the cellular origin of cardiosphere-derived cells (Cdcs)","volume":"117","author":"Marban","year":"2022","journal-title":"Basic Res Cardiol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.01.058","article-title":"Human cardiosphere-derived cells with activated mitochondria for better myocardial regenerative therapy","volume":"367","author":"Shiraishi","year":"2024","journal-title":"J Control Release"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jtcvs.2020.05.040","article-title":"Intrinsic activation of cardiosphere-derived cells enhances myocardial repair","volume":"163","author":"Sano","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B161","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00395-023-00995-2","article-title":"Three-vessel coronary infusion of cardiosphere-derived cells for the treatment of heart failure with preserved ejection fraction in a pre-clinical pig model","volume":"118","author":"Gallet","year":"2023","journal-title":"Basic Res Cardiol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00395-022-00913-y","article-title":"Uncovering the molecular identity of cardiosphere-derived cells (Cdcs) by single-cell rna sequencing","volume":"117","author":"Kogan","year":"2022","journal-title":"Basic Res Cardiol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-19-00035","article-title":"Allogeneic cardiosphere-derived cells for the treatment of heart failure with reduced ejection fraction: the dilated cardiomyopathy intervention with allogeneic myocardially-regenerative cells (Dynamic) trial","volume":"16","author":"Chakravarty","year":"2020","journal-title":"EuroIntervention"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab419","article-title":"Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice","volume":"42","author":"Lin","year":"2021","journal-title":"Eur Heart J"},{"key":"B165","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (Caduceus): A prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"B166","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41582-022-00657-2","article-title":"Treatment with cardiosphere-derived cells could slow progress of duchenne muscular dystrophy","volume":"18","author":"Lempriere","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0269-4","article-title":"Macrophages in cardiac repair: environmental cues and therapeutic strategies","volume":"51","author":"de Couto","year":"2019","journal-title":"Exp Mol Med"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-018-0216-z","article-title":"A mechanistic roadmap for the clinical application of cardiac cell therapies","volume":"2","author":"Marban","year":"2018","journal-title":"Nat BioMed Eng"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.640723","article-title":"Mechanistic and therapeutic implications of extracellular vesicles as a potential link between Covid-19 and cardiovascular disease manifestations","volume":"9","author":"Pironti","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00395-020-0795-1","article-title":"Allogeneic cardiosphere-derived cells (Cap-1002) in critically ill Covid-19 patients: compassionate-use case series","volume":"115","author":"Singh","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28894","article-title":"Cardioprotective role of extracellular vesicles: A highlight on exosome beneficial effects in cardiovascular diseases","volume":"234","author":"Rezaie","year":"2019","journal-title":"J Cell Physiol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115801","article-title":"Exosomal cargo: pro-angiogeneic, anti-inflammatory, and regenerative effects in ischemic and non-ischemic heart diseases - a comprehensive review","volume":"168","author":"Amirzadeh Gougheri","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112118","article-title":"Mesenchymal stem cell-derived exosome microrna as therapy for cardiac ischemic injury","volume":"143","author":"Nasser","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5802529","article-title":"Stem cell-derived exosomes: A potential alternative therapeutic agent in orthopaedics","volume":"2016","author":"Burke","year":"2016","journal-title":"Stem Cells Int"},{"key":"B175","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s13287-021-02542-z","article-title":"Mesenchymal stem cell-based therapy and exosomes in Covid-19: current trends and prospects","volume":"12","author":"Abdelgawad","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2281","article-title":"Mesenchymal stem cells and their derived exosomes to combat Covid-19","volume":"32","author":"Yousefi Dehbidi","year":"2022","journal-title":"Rev Med Virol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/cells10081959","article-title":"Mesenchymal stem cell-derived exosomes: applications in regenerative medicine","volume":"10","author":"Hade","year":"2021","journal-title":"Cells"},{"key":"B178","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ncrna.2022.01.001","article-title":"Exosomal rnas in diagnosis and therapies","volume":"7","author":"Narang","year":"2022","journal-title":"Noncoding RNA Res"},{"key":"B179","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jtcvs.2020.06.154","article-title":"Exosomes isolated from human cardiosphere-derived cells attenuate pressure overload-induced right ventricular dysfunction","volume":"162","author":"Bittle","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw240","article-title":"Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction","volume":"38","author":"Gallet","year":"2017","journal-title":"Eur Heart J"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00321","article-title":"The immunomodulatory signature of extracellular vesicles from cardiosphere-derived cells: A proteomic and mirna profiling","volume":"8","author":"Lopez","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.03.025","article-title":"Inhalation of msc-evs is a noninvasive strategy for ameliorating acute lung injury","volume":"345","author":"Zhao","year":"2022","journal-title":"J Control Release"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa042","article-title":"Statin therapy in Covid-19 infection","volume":"6","author":"Castiglione","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B184","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/pathogens9090759","article-title":"Statin use is associated with decreased risk of invasive mechanical ventilation in Covid-19 patients: A preliminary study","volume":"9","author":"Song","year":"2020","journal-title":"Pathogens"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2021.06.911","article-title":"Statin use and mortality in Covid-19 patients: updated systematic review and meta-analysis","volume":"330","author":"Kollias","year":"2021","journal-title":"Atherosclerosis"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2020.94655","article-title":"Statins and the Covid-19 main protease: in silico evidence on direct interaction","volume":"16","author":"Reiner","year":"2020","journal-title":"Arch Med Sci"},{"key":"B187","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/jcm9061909","article-title":"Cholesterol in relation to Covid-19: should we care about it","volume":"9","author":"Radenkovic","year":"2020","journal-title":"J Clin Med"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12150","article-title":"Effects of statin treatment on inflammation and cardiac function in heart failure: an adjusted indirect comparison meta-analysis of randomized trials","volume":"33","author":"Bonsu","year":"2015","journal-title":"Cardiovasc Ther"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2013.03.002","article-title":"Simvastatin induces apoptosis and disruption of the actin cytoskeleton in human dental pulp cells and periodontal ligament fibroblasts","volume":"58","author":"Saewong","year":"2013","journal-title":"Arch  Biol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bj.2020.12.002","article-title":"Phytochemicals against Sars-Cov as potential drug leads","volume":"44","author":"Swain","year":"2021","journal-title":"BioMed J"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107613","article-title":"Therapeutic potential of resveratrol against emerging respiratory viral infections","volume":"214","author":"Filardo","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B192","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12879-017-2253-8","article-title":"Effective inhibition of Mers-Cov infection by resveratrol","volume":"17","author":"Lin","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106893","article-title":"Effective inhibition of hcov-oc43 and Sars-Cov-2 by phytochemicals in vitro and in vivo","volume":"62","author":"Ojha","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.6916","article-title":"Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) in cultured vero cells","volume":"35","author":"Yang","year":"2021","journal-title":"Phytother Res"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.670955","article-title":"Can resveratrol-inhaled formulations be considered potential adjunct treatments for Covid-19","volume":"12","author":"Rossi","year":"2021","journal-title":"Front Immunol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/nu11050946","article-title":"Influence of resveratrol on the immune response","volume":"11","author":"Malaguarnera","year":"2019","journal-title":"Nutrients"},{"key":"B197","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.1038\/s41598-022-13920-9","article-title":"Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (Covid-19)","volume":"12","author":"McCreary","year":"2022","journal-title":"Sci Rep"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.33263\/briac114.1117211186","article-title":"Covid 19: resveratrol as a potential supplement to mitigate the cardiotoxicity associated with chloroquine and hydroxychloroquine treatment","volume":"11","author":"Rotimi","year":"2020","journal-title":"Biointerface Res Appl Chem"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107843","article-title":"Traditional chinese medicine (Tcm) in the treatment of Covid-19 and other viral infections: efficacies and mechanisms","volume":"225","author":"Huang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2021.0906","article-title":"Effectiveness and safety of traditional Chinese medicine in treating Covid-19: clinical evidence from China","volume":"12","author":"Xing","year":"2021","journal-title":"Aging Dis"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S424078","article-title":"Potential effects of traditional Chinese medicine on Covid-19 and cardiac injury: mechanisms and clinical evidence","volume":"16","author":"Fan","year":"2023","journal-title":"J Multidiscip Healthc"},{"key":"B202","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40249-020-00691-6","article-title":"Biological, clinical and epidemiological features of Covid-19, Sars and Mers and autodock simulation of ace2","volume":"9","author":"Zhang","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103101","article-title":"Immune environment modulation in pneumonia patients caused by coronavirus: Sars-Cov, Mers-Cov and Sars-Cov-2","volume":"12","author":"Yao","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01022","article-title":"Highlight of immune pathogenic response and hematopathologic effect in Sars-Cov, Mers-Cov, and Sars-Cov-2 infection","volume":"11","author":"Liang","year":"2020","journal-title":"Front Immunol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.17179\/excli2022-5355","article-title":"Comparative highlights on Mers-Cov, Sars-Cov-1, Sars-Cov-2, and Neo-Cov","volume":"21","author":"Goyal","year":"2022","journal-title":"EXCLI J"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166671","article-title":"Insight into the mechanisms of coronaviruses evading host innate immunity","volume":"1869","author":"Yao","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00563-y","article-title":"Acute myocarditis related to Covid-19: comparison to Sars and Mers","volume":"2","author":"Chasouraki","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-020-01311-x","article-title":"Severe acute respiratory syndrome (Sars), middle east respiratory syndrome (Mers), influenza, and Covid-19, beyond the lungs: A review article","volume":"126","author":"Lombardi","year":"2021","journal-title":"Radiol Med"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2020.0080","article-title":"Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe Covid-19","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells Dev"},{"key":"B210","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s13287-021-02482-8","article-title":"Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against Covid-19 infection-induced multiple organ dysfunction","volume":"12","author":"Safari","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1493306","article-title":"Caspase-1 activation, il-1\/il-6 signature and ifngamma-induced chemokines in lungs of Covid-19 patients","volume":"15","author":"Cambon","year":"2024","journal-title":"Front Immunol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01109-6","article-title":"Baricitinib in patients admitted to hospital with Covid-19 (Recovery): A randomised, controlled, open-label, platform trial and updated meta-analysis","volume":"400","author":"Group","year":"2022","journal-title":"Lancet"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104299","article-title":"Interleukin-1 and the nlrp3 inflammasome in Covid-19: pathogenetic and therapeutic implications","volume":"85","author":"Potere","year":"2022","journal-title":"EBioMedicine"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad084","article-title":"Nlrp3 inflammasome and interleukin-1 contributions to Covid-19-associated coagulopathy and immunothrombosis","volume":"119","author":"Potere","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2020.03.001","article-title":"Cardiac troponin I in patients with Coronavirus disease 2019 (Covid-19): evidence from a meta-analysis","volume":"63","author":"Lippi","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317186","article-title":"Covid-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis","volume":"106","author":"Imazio","year":"2020","journal-title":"Heart"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2096","article-title":"Circulating cardiovascular micrornas in critically ill Covid-19 patients","volume":"23","author":"Garg","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317070","article-title":"Sars-Cov-2-induced immune dysregulation and myocardial injury risk in China: insights from the Ers-Covid-19 study","volume":"127","author":"Li","year":"2020","journal-title":"Circ Res"},{"key":"B219","doi-asserted-by":"publisher","first-page":"10321","DOI":"10.1038\/s41598-023-37335-2","article-title":"The value of non-contrast chest ct in the prediction of myocardial injury in patients with the Covid-19 omicron variant","volume":"13","author":"Zhong","year":"2023","journal-title":"Sci Rep"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.22-355","article-title":"Different types of myocardial injury due to the severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) omicron variant","volume":"64","author":"Moriwaki","year":"2023","journal-title":"Int Heart J"},{"key":"B221","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41467-024-45400-1","article-title":"Frequency, kinetics and determinants of viable Sars-Cov-2 in bioaerosols from ambulatory Covid-19 patients infected with the beta, delta or omicron variants","volume":"15","author":"Jaumdally","year":"2024","journal-title":"Nat Commun"},{"key":"B222","doi-asserted-by":"publisher","first-page":"2400109","DOI":"10.2807\/1560-7917.ES.2024.29.10.2400109","article-title":"Effectiveness of omicron xbb.1.5 vaccine against infection with Sars-Cov-2 omicron xbb and jn.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024","volume":"29","author":"Huiberts","year":"2024","journal-title":"Euro Surveill"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27541","article-title":"Omicron (B.1.1.529): A new Sars-Cov-2 variant of concern mounting worldwide fear","volume":"94","author":"Thakur","year":"2022","journal-title":"J Med Virol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.03.008","article-title":"Echocardiographic findings in patients with Covid-19 with myocardial injury during the omicron variant surge","volume":"172","author":"Alam","year":"2022","journal-title":"Am J Cardiol"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1268213","article-title":"Development and validation of a prognostic model based on clinical laboratory biomarkers to predict admission to icu in omicron variant-infected hospitalized patients complicated with myocardial injury","volume":"15","author":"Yu","year":"2024","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1561946\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:11:26Z","timestamp":1747195886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1561946\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":225,"alternative-id":["10.3389\/fimmu.2025.1561946"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1561946","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"article-number":"1561946"}}